Novartis shells out $80M for Peninsula company's preclinical liver drug

Thanks in part to a six-person go-team testing fresh liver tissue from transplant patients at UCSF and Stanford, this young South San Francisco company has a "validating" deal.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 23, 2019 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news